Loading data for APVO — first visit, this takes a few seconds.
Aptevo Therapeutics Inc. (APVO)
NasdaqCM: APVO
· 실시간 가격 · USD
2.90
+0.09 (3.20%)
종가 기준: Aug 18, 2026, 8:00 PM
2.95
+1.72%
프리마켓: 6:58 AM
Aptevo Therapeutics Inc. (APVO) Stock Price, Analysis & Data
3.20% (1D)
데이터 없음
APVO 소개
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical bloo...
전체 기업 정보재무 실적
2025년 Aptevo Therapeutics의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -25.97M로, 7.61% 증가했습니다.
재무제표
